Reports

Industry Research Reports

Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-09-06

Pages: 117 Pages

Report ld: 5003687

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Tacrolimus market competitiveness, regional economic performance, and supply chain configurations.
The North America Tacrolimus market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Tacrolimus include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group, Takeda, Huapont Pharma, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Tacrolimus market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

  • GSK
  • Abbott
  • Roche Pharma
  • Novartis
  • Mylan
  • Squibb
  • Astellas
  • Aarti Group
  • Takeda
  • Huapont Pharma
  • Senju Pharmaceutical
  • Guike Pharmaceutical
  • Tecoland
  • Sandoz
  • ScinoPharm
  • RPG Life Science
  • Suzhou Pharmaceutical Technology
  • Accura Pharmaceuticals
  • Fujisawa Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Sinopharm Chuankang Pharmaceutical
  • Yamanouchi Pharmaceutical
  • Zhongmei Huadong Pharmaceutical
  • Hisun Pharmaceutical

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Tacrolimus Capsules
  • Tacrolimus Ointment
  • Tacrolimus Injection

Segment by Application

  • Hospitals
  • Clinics
  • Other

biaoTi Chapter Outline

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Tacrolimus market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Tacrolimus Ointment in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).

marn_i1

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

Table of Contents

muLu

1 Market Overview

1.1 Tacrolimus Product Scope

1.2 Tacrolimus by Type

1.2.1 Global Tacrolimus Sales by Type (2020 & 2024 & 2031)

1.2.2 Tacrolimus Capsules

1.2.3 Tacrolimus Ointment

1.2.4 Tacrolimus Injection

1.3 Tacrolimus by Application

1.3.1 Global Tacrolimus Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Tacrolimus Market Estimates and Forecasts (2020-2031)

1.4.1 Global Tacrolimus Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Tacrolimus Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Tacrolimus Price Trends (2020-2031)

1.5 Assumptions and Limitations

muLu

2 Market Size and Prospective by Region

2.1 Global Tacrolimus Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Tacrolimus Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Tacrolimus Sales Market Share by Region (2020-2025)

2.2.2 Global Tacrolimus Revenue Market Share by Region (2020-2025)

2.3 Global Tacrolimus Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Tacrolimus Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Tacrolimus Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Tacrolimus Market Size and Prospective (2020-2031)

2.4.2 Europe Tacrolimus Market Size and Prospective (2020-2031)

2.4.3 China Tacrolimus Market Size and Prospective (2020-2031)

2.4.4 Japan Tacrolimus Market Size and Prospective (2020-2031)

muLu

3 Global Market Size by Type

3.1 Global Tacrolimus Historic Market Review by Type (2020-2025)

3.1.1 Global Tacrolimus Sales by Type (2020-2025)

3.1.2 Global Tacrolimus Revenue by Type (2020-2025)

3.1.3 Global Tacrolimus Price by Type (2020-2025)

3.2 Global Tacrolimus Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Tacrolimus Sales Forecast by Type (2026-2031)

3.2.2 Global Tacrolimus Revenue Forecast by Type (2026-2031)

3.2.3 Global Tacrolimus Price Forecast by Type (2026-2031)

3.3 Different Types Tacrolimus Representative Players

muLu

4 Global Market Size by Application

4.1 Global Tacrolimus Historic Market Review by Application (2020-2025)

4.1.1 Global Tacrolimus Sales by Application (2020-2025)

4.1.2 Global Tacrolimus Revenue by Application (2020-2025)

4.1.3 Global Tacrolimus Price by Application (2020-2025)

4.2 Global Tacrolimus Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Tacrolimus Sales Forecast by Application (2026-2031)

4.2.2 Global Tacrolimus Revenue Forecast by Application (2026-2031)

4.2.3 Global Tacrolimus Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Tacrolimus Application

muLu

5 Competition Landscape by Players

5.1 Global Tacrolimus Sales by Players (2020-2025)

5.2 Global Top Tacrolimus Players by Revenue (2020-2025)

5.3 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2024)

5.4 Global Tacrolimus Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Tacrolimus, Product Type & Application

5.7 Global Key Manufacturers of Tacrolimus, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Tacrolimus Sales by Company

6.1.1.1 North America Tacrolimus Sales by Company (2020-2025)

6.1.1.2 North America Tacrolimus Revenue by Company (2020-2025)

6.1.2 North America Tacrolimus Sales Breakdown by Type (2020-2025)

6.1.3 North America Tacrolimus Sales Breakdown by Application (2020-2025)

6.1.4 North America Tacrolimus Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Tacrolimus Sales by Company

6.2.1.1 Europe Tacrolimus Sales by Company (2020-2025)

6.2.1.2 Europe Tacrolimus Revenue by Company (2020-2025)

6.2.2 Europe Tacrolimus Sales Breakdown by Type (2020-2025)

6.2.3 Europe Tacrolimus Sales Breakdown by Application (2020-2025)

6.2.4 Europe Tacrolimus Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Tacrolimus Sales by Company

6.3.1.1 China Tacrolimus Sales by Company (2020-2025)

6.3.1.2 China Tacrolimus Revenue by Company (2020-2025)

6.3.2 China Tacrolimus Sales Breakdown by Type (2020-2025)

6.3.3 China Tacrolimus Sales Breakdown by Application (2020-2025)

6.3.4 China Tacrolimus Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Tacrolimus Sales by Company

6.4.1.1 Japan Tacrolimus Sales by Company (2020-2025)

6.4.1.2 Japan Tacrolimus Revenue by Company (2020-2025)

6.4.2 Japan Tacrolimus Sales Breakdown by Type (2020-2025)

6.4.3 Japan Tacrolimus Sales Breakdown by Application (2020-2025)

6.4.4 Japan Tacrolimus Major Customer

6.4.5 Japan Market Trend and Opportunities

muLu

7 Company Profiles and Key Figures

7.1 GSK

7.1.1 GSK Company Information

7.1.2 GSK Business Overview

7.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.1.4 GSK Tacrolimus Products Offered

7.1.5 GSK Recent Development

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Business Overview

7.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Abbott Tacrolimus Products Offered

7.2.5 Abbott Recent Development

7.3 Roche Pharma

7.3.1 Roche Pharma Company Information

7.3.2 Roche Pharma Business Overview

7.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Roche Pharma Tacrolimus Products Offered

7.3.5 Roche Pharma Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Business Overview

7.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Novartis Tacrolimus Products Offered

7.4.5 Novartis Recent Development

7.5 Mylan

7.5.1 Mylan Company Information

7.5.2 Mylan Business Overview

7.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Mylan Tacrolimus Products Offered

7.5.5 Mylan Recent Development

7.6 Squibb

7.6.1 Squibb Company Information

7.6.2 Squibb Business Overview

7.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Squibb Tacrolimus Products Offered

7.6.5 Squibb Recent Development

7.7 Astellas

7.7.1 Astellas Company Information

7.7.2 Astellas Business Overview

7.7.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Astellas Tacrolimus Products Offered

7.7.5 Astellas Recent Development

7.8 Aarti Group

7.8.1 Aarti Group Company Information

7.8.2 Aarti Group Business Overview

7.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Aarti Group Tacrolimus Products Offered

7.8.5 Aarti Group Recent Development

7.9 Takeda

7.9.1 Takeda Company Information

7.9.2 Takeda Business Overview

7.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Takeda Tacrolimus Products Offered

7.9.5 Takeda Recent Development

7.10 Huapont Pharma

7.10.1 Huapont Pharma Company Information

7.10.2 Huapont Pharma Business Overview

7.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Huapont Pharma Tacrolimus Products Offered

7.10.5 Huapont Pharma Recent Development

7.11 Senju Pharmaceutical

7.11.1 Senju Pharmaceutical Company Information

7.11.2 Senju Pharmaceutical Business Overview

7.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Senju Pharmaceutical Tacrolimus Products Offered

7.11.5 Senju Pharmaceutical Recent Development

7.12 Guike Pharmaceutical

7.12.1 Guike Pharmaceutical Company Information

7.12.2 Guike Pharmaceutical Business Overview

7.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Guike Pharmaceutical Tacrolimus Products Offered

7.12.5 Guike Pharmaceutical Recent Development

7.13 Tecoland

7.13.1 Tecoland Company Information

7.13.2 Tecoland Business Overview

7.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Tecoland Tacrolimus Products Offered

7.13.5 Tecoland Recent Development

7.14 Sandoz

7.14.1 Sandoz Company Information

7.14.2 Sandoz Business Overview

7.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Sandoz Tacrolimus Products Offered

7.14.5 Sandoz Recent Development

7.15 ScinoPharm

7.15.1 ScinoPharm Company Information

7.15.2 ScinoPharm Business Overview

7.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.15.4 ScinoPharm Tacrolimus Products Offered

7.15.5 ScinoPharm Recent Development

7.16 RPG Life Science

7.16.1 RPG Life Science Company Information

7.16.2 RPG Life Science Business Overview

7.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.16.4 RPG Life Science Tacrolimus Products Offered

7.16.5 RPG Life Science Recent Development

7.17 Suzhou Pharmaceutical Technology

7.17.1 Suzhou Pharmaceutical Technology Company Information

7.17.2 Suzhou Pharmaceutical Technology Business Overview

7.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Suzhou Pharmaceutical Technology Tacrolimus Products Offered

7.17.5 Suzhou Pharmaceutical Technology Recent Development

7.18 Accura Pharmaceuticals

7.18.1 Accura Pharmaceuticals Company Information

7.18.2 Accura Pharmaceuticals Business Overview

7.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.18.4 Accura Pharmaceuticals Tacrolimus Products Offered

7.18.5 Accura Pharmaceuticals Recent Development

7.19 Fujisawa Pharmaceutical

7.19.1 Fujisawa Pharmaceutical Company Information

7.19.2 Fujisawa Pharmaceutical Business Overview

7.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.19.4 Fujisawa Pharmaceutical Tacrolimus Products Offered

7.19.5 Fujisawa Pharmaceutical Recent Development

7.20 Sichuan Med-Shine Pharmaceutical

7.20.1 Sichuan Med-Shine Pharmaceutical Company Information

7.20.2 Sichuan Med-Shine Pharmaceutical Business Overview

7.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Products Offered

7.20.5 Sichuan Med-Shine Pharmaceutical Recent Development

7.21 Sinopharm Chuankang Pharmaceutical

7.21.1 Sinopharm Chuankang Pharmaceutical Company Information

7.21.2 Sinopharm Chuankang Pharmaceutical Business Overview

7.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Products Offered

7.21.5 Sinopharm Chuankang Pharmaceutical Recent Development

7.22 Yamanouchi Pharmaceutical

7.22.1 Yamanouchi Pharmaceutical Company Information

7.22.2 Yamanouchi Pharmaceutical Business Overview

7.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.22.4 Yamanouchi Pharmaceutical Tacrolimus Products Offered

7.22.5 Yamanouchi Pharmaceutical Recent Development

7.23 Zhongmei Huadong Pharmaceutical

7.23.1 Zhongmei Huadong Pharmaceutical Company Information

7.23.2 Zhongmei Huadong Pharmaceutical Business Overview

7.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Products Offered

7.23.5 Zhongmei Huadong Pharmaceutical Recent Development

7.24 Hisun Pharmaceutical

7.24.1 Hisun Pharmaceutical Company Information

7.24.2 Hisun Pharmaceutical Business Overview

7.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)

7.24.4 Hisun Pharmaceutical Tacrolimus Products Offered

7.24.5 Hisun Pharmaceutical Recent Development

muLu

8 Tacrolimus Manufacturing Cost Analysis

8.1 Tacrolimus Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Tacrolimus

8.4 Tacrolimus Industrial Chain Analysis

muLu

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Tacrolimus Distributors List

9.3 Tacrolimus Customers

muLu

10 Tacrolimus Market Dynamics

10.1 Tacrolimus Industry Trends

10.2 Tacrolimus Market Drivers

10.3 Tacrolimus Market Challenges

10.4 Tacrolimus Market Restraints

muLu

11 Research Findings and Conclusion

muLu

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

den_biaoTiZhungShi

Table of Figures

muLu

List of Tables

Table 1. Global Tacrolimus Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Tacrolimus Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Tacrolimus Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Tacrolimus Sales (K MT) by Region (2020-2025)
Table 5. Global Tacrolimus Sales Market Share by Region (2020-2025)
Table 6. Global Tacrolimus Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Tacrolimus Revenue Share by Region (2020-2025)
Table 8. Global Tacrolimus Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Tacrolimus Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Tacrolimus Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Tacrolimus Revenue Share Forecast by Region (2026-2031)
Table 12. Global Tacrolimus Sales by Type (K MT) & (2020-2025)
Table 13. Global Tacrolimus Sales Share by Type (2020-2025)
Table 14. Global Tacrolimus Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Tacrolimus Price by Type (USD/MT) & (2020-2025)
Table 16. Global Tacrolimus Sales by Type (K MT) & (2026-2031)
Table 17. Global Tacrolimus Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Tacrolimus Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Tacrolimus Sales by Application (K MT) & (2020-2025)
Table 21. Global Tacrolimus Sales Share by Application (2020-2025)
Table 22. Global Tacrolimus Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Tacrolimus Price by Application (USD/MT) & (2020-2025)
Table 24. Global Tacrolimus Sales by Application (K MT) & (2026-2031)
Table 25. Global Tacrolimus Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Tacrolimus Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Tacrolimus Application
Table 28. Global Tacrolimus Sales by Company (K MT) & (2020-2025)
Table 29. Global Tacrolimus Sales Share by Company (2020-2025)
Table 30. Global Tacrolimus Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Tacrolimus Revenue Share by Company (2020-2025)
Table 32. Global Tacrolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2024)
Table 33. Global Market Tacrolimus Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Tacrolimus, Product Type & Application
Table 36. Global Key Manufacturers of Tacrolimus, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Tacrolimus Sales by Company (2020-2025) & (K MT)
Table 39. North America Tacrolimus Sales Market Share by Company (2020-2025)
Table 40. North America Tacrolimus Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Tacrolimus Revenue Market Share by Company (2020-2025)
Table 42. North America Tacrolimus Sales by Type (2020-2025) & (K MT)
Table 43. North America Tacrolimus Sales Market Share by Type (2020-2025)
Table 44. North America Tacrolimus Sales by Application (2020-2025) & (K MT)
Table 45. North America Tacrolimus Sales Market Share by Application (2020-2025)
Table 46. Europe Tacrolimus Sales by Company (2020-2025) & (K MT)
Table 47. Europe Tacrolimus Sales Market Share by Company (2020-2025)
Table 48. Europe Tacrolimus Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Tacrolimus Revenue Market Share by Company (2020-2025)
Table 50. Europe Tacrolimus Sales by Type (2020-2025) & (K MT)
Table 51. Europe Tacrolimus Sales Market Share by Type (2020-2025)
Table 52. Europe Tacrolimus Sales by Application (2020-2025) & (K MT)
Table 53. Europe Tacrolimus Sales Market Share by Application (2020-2025)
Table 54. China Tacrolimus Sales by Company (2020-2025) & (K MT)
Table 55. China Tacrolimus Sales Market Share by Company (2020-2025)
Table 56. China Tacrolimus Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Tacrolimus Revenue Market Share by Company (2020-2025)
Table 58. China Tacrolimus Sales by Type (2020-2025) & (K MT)
Table 59. China Tacrolimus Sales Market Share by Type (2020-2025)
Table 60. China Tacrolimus Sales by Application (2020-2025) & (K MT)
Table 61. China Tacrolimus Sales Market Share by Application (2020-2025)
Table 62. Japan Tacrolimus Sales by Company (2020-2025) & (K MT)
Table 63. Japan Tacrolimus Sales Market Share by Company (2020-2025)
Table 64. Japan Tacrolimus Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Tacrolimus Revenue Market Share by Company (2020-2025)
Table 66. Japan Tacrolimus Sales by Type (2020-2025) & (K MT)
Table 67. Japan Tacrolimus Sales Market Share by Type (2020-2025)
Table 68. Japan Tacrolimus Sales by Application (2020-2025) & (K MT)
Table 69. Japan Tacrolimus Sales Market Share by Application (2020-2025)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. GSK Tacrolimus Product
Table 74. GSK Recent Development
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Abbott Tacrolimus Product
Table 79. Abbott Recent Development
Table 80. Roche Pharma Company Information
Table 81. Roche Pharma Description and Business Overview
Table 82. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Roche Pharma Tacrolimus Product
Table 84. Roche Pharma Recent Development
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Novartis Tacrolimus Product
Table 89. Novartis Recent Development
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Mylan Tacrolimus Product
Table 94. Mylan Recent Development
Table 95. Squibb Company Information
Table 96. Squibb Description and Business Overview
Table 97. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Squibb Tacrolimus Product
Table 99. Squibb Recent Development
Table 100. Astellas Company Information
Table 101. Astellas Description and Business Overview
Table 102. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Astellas Tacrolimus Product
Table 104. Astellas Recent Development
Table 105. Aarti Group Company Information
Table 106. Aarti Group Description and Business Overview
Table 107. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Aarti Group Tacrolimus Product
Table 109. Aarti Group Recent Development
Table 110. Takeda Company Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Takeda Tacrolimus Product
Table 114. Takeda Recent Development
Table 115. Huapont Pharma Company Information
Table 116. Huapont Pharma Description and Business Overview
Table 117. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Huapont Pharma Tacrolimus Product
Table 119. Huapont Pharma Recent Development
Table 120. Senju Pharmaceutical Company Information
Table 121. Senju Pharmaceutical Description and Business Overview
Table 122. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Senju Pharmaceutical Tacrolimus Product
Table 124. Senju Pharmaceutical Recent Development
Table 125. Guike Pharmaceutical Company Information
Table 126. Guike Pharmaceutical Description and Business Overview
Table 127. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Guike Pharmaceutical Tacrolimus Product
Table 129. Guike Pharmaceutical Recent Development
Table 130. Tecoland Company Information
Table 131. Tecoland Description and Business Overview
Table 132. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Tecoland Tacrolimus Product
Table 134. Tecoland Recent Development
Table 135. Sandoz Company Information
Table 136. Sandoz Description and Business Overview
Table 137. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Sandoz Tacrolimus Product
Table 139. Sandoz Recent Development
Table 140. ScinoPharm Company Information
Table 141. ScinoPharm Description and Business Overview
Table 142. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. ScinoPharm Tacrolimus Product
Table 144. ScinoPharm Recent Development
Table 145. RPG Life Science Company Information
Table 146. RPG Life Science Description and Business Overview
Table 147. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 148. RPG Life Science Tacrolimus Product
Table 149. RPG Life Science Recent Development
Table 150. Suzhou Pharmaceutical Technology Company Information
Table 151. Suzhou Pharmaceutical Technology Description and Business Overview
Table 152. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 153. Suzhou Pharmaceutical Technology Tacrolimus Product
Table 154. Suzhou Pharmaceutical Technology Recent Development
Table 155. Accura Pharmaceuticals Company Information
Table 156. Accura Pharmaceuticals Description and Business Overview
Table 157. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 158. Accura Pharmaceuticals Tacrolimus Product
Table 159. Accura Pharmaceuticals Recent Development
Table 160. Fujisawa Pharmaceutical Company Information
Table 161. Fujisawa Pharmaceutical Description and Business Overview
Table 162. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 163. Fujisawa Pharmaceutical Tacrolimus Product
Table 164. Fujisawa Pharmaceutical Recent Development
Table 165. Sichuan Med-Shine Pharmaceutical Company Information
Table 166. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 167. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 168. Sichuan Med-Shine Pharmaceutical Tacrolimus Product
Table 169. Sichuan Med-Shine Pharmaceutical Recent Development
Table 170. Sinopharm Chuankang Pharmaceutical Company Information
Table 171. Sinopharm Chuankang Pharmaceutical Description and Business Overview
Table 172. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 173. Sinopharm Chuankang Pharmaceutical Tacrolimus Product
Table 174. Sinopharm Chuankang Pharmaceutical Recent Development
Table 175. Yamanouchi Pharmaceutical Company Information
Table 176. Yamanouchi Pharmaceutical Description and Business Overview
Table 177. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 178. Yamanouchi Pharmaceutical Tacrolimus Product
Table 179. Yamanouchi Pharmaceutical Recent Development
Table 180. Zhongmei Huadong Pharmaceutical Company Information
Table 181. Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 182. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 183. Zhongmei Huadong Pharmaceutical Tacrolimus Product
Table 184. Zhongmei Huadong Pharmaceutical Recent Development
Table 185. Hisun Pharmaceutical Company Information
Table 186. Hisun Pharmaceutical Description and Business Overview
Table 187. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 188. Hisun Pharmaceutical Tacrolimus Product
Table 189. Hisun Pharmaceutical Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Tacrolimus Distributors List
Table 193. Tacrolimus Customers List
Table 194. Tacrolimus Market Trends
Table 195. Tacrolimus Market Drivers
Table 196. Tacrolimus Market Challenges
Table 197. Tacrolimus Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Tacrolimus Product Picture
Figure 2. Global Tacrolimus Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Tacrolimus Sales Market Share by Type in 2024 & 2031
Figure 4. Tacrolimus Capsules Product Picture
Figure 5. Tacrolimus Ointment Product Picture
Figure 6. Tacrolimus Injection Product Picture
Figure 7. Global Tacrolimus Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Tacrolimus Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals Examples
Figure 10. Clinics Examples
Figure 11. Other Examples
Figure 12. Global Tacrolimus Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tacrolimus Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Tacrolimus Sales (K MT) Growth Rate (2020-2031)
Figure 15. Global Tacrolimus Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 16. Tacrolimus Report Years Considered
Figure 17. Global Market Tacrolimus Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Tacrolimus Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Tacrolimus Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Tacrolimus Sales (K MT) Growth Rate (2020-2031)
Figure 21. Europe Tacrolimus Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Tacrolimus Sales (K MT) Growth Rate (2020-2031)
Figure 23. China Tacrolimus Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Tacrolimus Sales (K MT) Growth Rate (2020-2031)
Figure 25. Japan Tacrolimus Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Tacrolimus Sales (K MT) Growth Rate (2020-2031)
Figure 27. Global Tacrolimus Revenue Share by Type (2020-2025)
Figure 28. Global Tacrolimus Sales Share by Type (2026-2031)
Figure 29. Global Tacrolimus Revenue Share by Type (2026-2031)
Figure 30. Global Tacrolimus Revenue Share by Application (2020-2025)
Figure 31. Global Tacrolimus Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Tacrolimus Sales Share by Application (2026-2031)
Figure 33. Global Tacrolimus Revenue Share by Application (2026-2031)
Figure 34. Global Tacrolimus Sales Share by Company (2024)
Figure 35. Global Tacrolimus Revenue Share by Company (2024)
Figure 36. Global 5 Largest Tacrolimus Players Market Share by Revenue in Tacrolimus: 2020 & 2024
Figure 37. Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Tacrolimus
Figure 39. Manufacturing Process Analysis of Tacrolimus
Figure 40. Tacrolimus Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
den_biaoTiZhungShi

Related Reports

Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-09-06

Pages: 117 Pages

Report ld: 5003687

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English

English

Online

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:

REPORT COVERAGE

zhankai
den_ic7

Market Segmentation

den_ic7

Why This Report?

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

Interest In This Report?

Get A Free Sample

Pre-Order Enquiry

OR

Need a Tailored Report?

Customize this report to your needs.

Customize This Report

den_gou

Fact Checked

den_gou

Cite this Research

biaoTi

WORLD WIDE OFFICE